Welcome. If you're a registered user, please log-in. If not, please sign-up.
  • registrations@informa-ls.com
  • phone:+44(0)20 7017 7481
  • GO

5th Annual Pharmaceutical Labelling & Packaging Conference

Key Advice on Regulatory Changes Affecting Packaging & Labelling

Europe’s most trusted event providing all you need to know on pharmaceutical packaging and labelling from Association leaders, Regulators, industry experts and respected pioneers in the field.

 

Valuable advice given during 3 new key opening presentations on meeting patient needs through effective packaging and labelling:

  1. Ilaria Passarani, BEUC - The European Consumers Organisation
  2. Helen Taylor, PAGB - The Proprietary Association of Great Britain
  3. Dr Michael Wilks, CPME; eHealth Users' Stakeholder Group

Your expert speaker panel will include:

Your expert speaker panel will include:

Linda Grohsová Non-Clinical Assessor Czech State Institute for Drug Control

Dr Karel van der Waarde Consultant/Professor Graphic design - Research/Avans University

Petra Baddack GRA - Head of Europe, Regulatory Affairs Coordination Abbott Products GmbH

Anna Wachnik-Święcicka Head, Product Information Evaluation Poland

Helen Taylor Codes of Practice Executive PAGB

Ines Becker-Schnoor Manager Global Regulatory Affairs Liaison Abbott Product GmbH

Janice Kite Director Healthcare Traceability GS1 Global Office

Jim Thomson Chair European Alliance for Safe Medicines


..

Sponsors

..
..
..
..

Exhibitors

..
..
..
..

Promotional Participant

..
..
..

Where and When?

 20-21 October 2010

Holiday Inn London - Regent's Park, UK

*Co-located with Informa's Annual Packaging & Labelling for Medical  Devices*

DON'T MISS: Add-Ons

 

19 October 2010: Pre Conference Workshop

Written Information Provision beyond the EU: Spotlight on the Americas 

Attendees will have the opportunity to share information and learn from emerging trends outside the EU, as well as gain knowledge that may affect attendees directly, relating to global product launches and licensing maintenance in the Americas.

 ---------------------------------

 

20 October 2010: Evening Seminar & Dinner

Looking at Information about Medicines: Is It Really What We Want?

Attendees will learn about continuously re-occurring practical issues and limits of the systems that prevent us from providing patients with information that is personalised, appropriate, relevant and respectful.

Reviews

"Good to see everyone in dialogue with the same issues. Good opportunity to gain contacts to help on common issues"
Delegate
Sanofi Aventis
"Ideal forum to get an update on what's going on in the real world"
Delegate
Johnson & Johnson
..

Advertising banners

..
..
..

Media Partners

Media Partners
Media Partners
Media Partners
Media Partners
Media Partners

Download Latest Information Now

(updated 1 September 2010)

Poll

Do you think the SmPC guideline has achieved the balance of risk vs benefit?

 
 

 

2010 Expert Speaker Panel

Dominique Westphal, EU-Cooperation, Paul-Ehrlich-Institute, Germany Linda Grohsová, Non-Clinical Assessor, State Institute for Drug Control, Czech Republic Anna Wachnik-Swiecicka, Head of Section for Product Information, Office for Registration of Medicinal Products, Medical Devices and Biocides, Poland
Ilaria Passarani, Senior Policy Officer, BEUC –The European Consumers' Organisation, Belgium Helen Taylor, Codes of Practice Executive, PAGB (The Proprietary Association of Great Britain), UK Dr Michael Wilks, Immediate Past President, CPME; Chairman, eHealth Users' Stakeholder Group, Belgium
Janice Kite, Director Healthcare Traceability, GS1 Global Office, UK Jim Thomson, Chair, European Alliance for Safe Medicines, UK Dr Susanne Sommer, MDRA, Labelling Expert, Global Regulatory Product Information, Merck KGaA, Germany
David Howard, Director, Global Brand Protection, Johnson & Johnson, USA Petra Baddack, GRA - Head of Europe, Regulatory Affairs Coordination, Abbott Products GmbH, Germany Lisa Roberts, Regulatory Project Manager, Global Regulatory Affairs – Labelling, GlaxoSmithKline, UK
Fiona Reekie, Director, Global Regulatory Affairs Strategic Policy & Support, Johnson & Johnson Pharmaceutical Group, UK Ines Becker-Schnoor, Manager Global Regulatory Affairs Liaison, Abbott Product GmbH, Germany
Dr Maria Belle, Drug Safety & Pharmacovigilance, Manager Aggregate Reports, Novartis Consumer Health SA, Switzerland (to be confirmed) Philippe Auclair, Senior Director, Regulatory Strategy and Advocacy, Abbott Quality & Regulatory EMEA, Abbott Vascular International, Belgium
Mark Gibson, Consumer Information Specialist, UK Dr Karel van der Waarde, Consultant, Professor, Graphic Design – Research, Avans University, Germany

Bookmark and Share